* Newstin.co.uk is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.co.uk and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.co.uk is for sale! *

Urology

Atlanta Urology and the Emory Urology Department Provide Best Treatment [Newsalistic]

feeds4all.nl
14 hrs ago
        

Emory Urology center provides treatment for many conditions and diseases for example, prostate cancer, bladder cancer, kidney cancer are all treated by Emory Urologists. The Emory Department of Urology provides prostate cancer...

add comment
                   

Nymox NX-1207 Successful Clinical Trial Results Featured in Urology Times

finanznachrichten.de
yesterday 6 related
        

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is please to announce that the presentation of NX-1207 clinical study data at the AUA South Central Section annual meeting in Santa Ana Pueblo, NM was featured in the Urology...

add comment
                   

Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic...

pharmiweb.co.uk
10-Oct-2008 10 related
        

Watson Pharmaceuticals Posted on:10 Oct 08 CORONA, Calif., Oct. 8 /PRNewswire-FirstCall/ Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the U.S. Food and Drug...

add comment
                   
pharmiweb.co.uk: Reuters Deals Today pharmiweb.co.uk

Watson gets FDA approval for BPH drug silodosin

pharmiweb.co.uk
10-Oct-2008 11 related
        

Watson Pharmaceuticals, best-known as a generics company, has received approval from US regulators for Rapaflo, a new alpha blocker for the treatment of enlarged prostate. The US Food and Drug Administration has given the...

add comment
                   

InvestSource, Inc.: Heart Health Inc. Commences Plan to Reduce Authorized Shares by 75%

tmcnet.com
10-Oct-2008 4 related
        

Stocks in the News: Heart Health, Inc. (Other OTC:HHEL.PK), Intuitive Surgical, Inc. (Nasdaq: ISRG), American Medical Systems, Inc. (NASDAQ: AMMD), Boston Scientific (NYSE: BSX) October 9, 2008 -- Heart Health, Inc. (Other...

add comment
                   

New fiber extends the use of the GreenLight Laser System beyond BPH

finanznachrichten.de
09-Oct-2008 2 related
        

American Medical Systems, Inc. (AMS) (NASDAQ: AMMD) today announced the launch of its new GreenLight HPS (High Performance System) EA (Extended Applications) Fiber intended for the treatment of bladder tumors and urethral...

add comment
                   

Urodynamix's Near Infrared Spectroscopy (NIRS) Technology In Urology Were Published In Two Journals

medicalnewstoday.com
09-Oct-2008 1 related
        

Urodynamix Technologies Ltd. (TSX-V:URO) today announced that two peer-reviewed articles related to the application of its near infrared spectroscopy (NIRS) technology in urology were published in the October 2008 edition of...

add comment
                   

International drug study shows rapid improvement in overactive bladder symptoms

eurekalert.org
09-Oct-2008 6 related
        

Patient using solifenacin reported that their overactive bladder problems improved by 70 percent. Improvements were noted as early as 3 days in the double-blind randomized study which involved 863 patients from 14 countries....

add comment

Learn About the Minimally Invasive Surgical Devices, World Market

tmcnet.com
09-Oct-2008 1 related
        

LONDON, UNITED KINGDOM, October 9 / MARKET WIRE/ -- Minimally Invasive Surgical Devices, World Market http://www.reportlinker.com/p096410/Minimally-Invasive-Surgical-Devices-World-Ma rket.html Minimally invasive surgery (MIS)...

add comment
                   

Watson Announces Positive Data for Its Investigational Oxybutynin Topical Gel for the Treatment...

redorbit.com
08-Oct-2008 7 related
        

Posted on: Wednesday, 8 October 2008, 09:00 CDT CORONA, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that investigators presented clinical...

add comment
1 2 3 4 5 next »